Pioglitazone (Actos)
Pioglitazone is the third thiazolidinedione ("glitazone") to be marketed in the USA for treatment of type 2 diabetes. Thiazolidinediones decrease resistance to insulin....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Pioglitazone (Actos)
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1066
Article Code: 1066c
Date: November 19, 1999
Volume: 41
Page: 112
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1066
Article Code: 1066c
Date: November 19, 1999
Volume: 41
Page: 112
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)